The article answers the most important questions about the new personalized cancer vaccine Intismeran against melanoma, which shows promising results in combination with Keytruda, and discusses the potential impact on other cancer types as well as the chances of approval in Germany. #KrebsImpfung #Intismeran #MedizinDurchbruch (translated)
Despite successful results of a new cancer vaccine, Moderna's stock fell by 17.6 percent, as investors had higher expectations after a prior price rally, explains market expert Jürgen Schmitt. #Moderna #Krebsimpfung #Aktienmarkt (translated)